{"id":"W2947888232","doi":"10.1200/jco.2019.37.15_suppl.3142","title":"Effects of immune architecture on response to adjuvant capecitabine in triple-negative breast cancer (FinXX trial).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Epirubicin; Docetaxel; Triple-negative breast cancer; Internal medicine; Oncology; Cyclophosphamide; Breast cancer; Gene signature; Chemotherapy; Adjuvant; Cancer; Colorectal cancer; Gene expression","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001123174,0.0005360165,0.0007800166,0.0001888095,0.0001691822,0.0004431082,0.0002785563,0.0004755211,0.002145425],"category_scores_gemma":[0.000738411,0.0001428911,0.0006811416,0.0001590209,0.0002932417,0.0003391165,0.0002149,0.0006465532,0.0001925964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000485887,"about_ca_system_score_gemma":0.0002922322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000711389,"about_ca_topic_score_gemma":0.001700087,"domain_scores_codex":[0.9997959,0.0001042519,0.00001065294,0.00003926054,0.00001832828,0.00003172586],"domain_scores_gemma":[0.9997479,0.0000820123,0.000072462,0.00001904536,0.00001349959,0.00006502641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8181479,0.002044307,0.04923923,0.0009125658,0.001902491,0.0001333722,0.00007374844,0.002872788,0.01126298,0.0002233433,0.00249926,0.110688],"study_design_scores_gemma":[0.2892632,0.2601759,0.4205868,0.0003508512,0.005974466,0.001123883,0.0001282177,0.006781464,0.006240875,0.001253268,0.008035586,0.00008549078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955643,0.002511295,0.0001083151,0.0001437629,0.00004480303,0.0001260899,0.0003918961,0.00001997016,0.001089495],"genre_scores_gemma":[0.9971494,0.000477869,0.0002293,0.0001681234,0.00003867815,0.0001187376,0.0009327845,0.000004551455,0.0008805994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002145425,"threshold_uncertainty_score":0.007177234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04443171687605387,"score_gpt":0.4700165287027677,"score_spread":0.4255848118267138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}